Zobrazeno 1 - 5
of 5
pro vyhledávání: '"V. B. Trivedi"'
Autor:
G S Kasat, J C Patel, M V Patil, D P Kumar, V B Kute, P R Shah, H V Patel, P R Modi, V R Shah, V B Trivedi, H L Trivedi
Publikováno v:
Indian Journal of Transplantation, Vol 13, Iss 3, Pp 234-235 (2019)
The positive complement-dependent cytotoxicity crossmatch (CDCXM) is considered as a contraindication for renal transplantation (RT) since long in an effort to avoid immediate rejection. There has been tremendous development in our understanding of t
Externí odkaz:
https://doaj.org/article/03cdf28e135f4cb592fe19dbcf5fe61c
Autor:
H L, Trivedi, H, Kaneku, P I, Terasaki, A, Feroz, A V, Vanikar, V B, Trivedi, S I, Khemchandani, S D, Dave, P R, Modi, F, Jahr, A, Idica, M J, Everly
Publikováno v:
Clinical transplants.
A total of 69 individuals received a kidney from a living donor after a TLI-based clonal deletion protocol with no post-transplant maintenance immunosuppression planned. If needed, immunosuppression was started on a patient-specific basis, adding one
Autor:
H, Kaneku, A, Idica, M J, Everly, P I, Terasaki, A, Feroz, A V, Vanikar, V, Shankar, V B, Trivedi, P R, Modi, S I, Khemchandani, S D, Dave, H L, Trivedi
Publikováno v:
Clinical transplants.
1. A total of 61 patients were treated with a clonal deletion protocol and transplanted without planned post-transplant immunosuppression. 2. Twenty-nine (48%) patients did not develop any donor-specific anti-HLA antibodies after the transplant, with
Autor:
A, Idica, H, Kaneku, M J, Everly, H L, Trivedi, A, Feroz, A V, Vanikar, V, Shankar, V B, Trivedi, P R, Modi, S I, Khemchandani, S D, Dave, P I, Terasaki
Publikováno v:
Clinical transplants.
We show the ability of bortezomib to remove donor-specific HLA antibody from kidney allograft patients, the drug acting as a proteasome inhibitor, providing targeted therapy against antibody-producing plasma cells. Ten out of thirteen patients (77%)
Autor:
M. Sugawara, S. Ichimura, K. Kokubo, T. Shimbo, M. Hirose, H. Kobayashi, P. Hribova, I. Brabcova, E. Honsova, O. Viklicky, V. B. Kute, P. R. Shah, A. V. Vanikar, M. R. Gumber, H. V. Patel, P. R. Modi, H. L. Trivedi, V. B. Trivedi, S. Nusrath, M. Minz, R. Walker Minz, A. Sharma, S. Singh, V. Jha, K. Joshi, R. Richter, S. Kohler, S. Qidan, E. Scheuermann, H.-G. Kachel, J. Gossmann, S. Gauer, E. Seifried, H. Geiger, C. Seidl, I. A. Hauser, L. Hanssen, B. Frye, T. Ostendorf, C. Alidousty, S. Djudjaj, P. Boor, T. Rauen, J. Floege, P. Mertens, U. Raffetseder, B. Garcia-Cenador, J. M. Lopez-Novoa, M. Iniguez, V. Fernandez, P. Perez de Obanos, J. Ruiz, J. R. Sanz-Gimenez, J. F. Lopez-Marcos, J. Garcia-Criado, A. H. Van Craenenbroeck, S. H. Anguille, A. Jurgens, N. Cools, K. Van Camp, B. Stein, G. Nijs, Z. Berneman, M. Ieven, P. Van Damme, V. Van Tendeloo, G. A. Verpooten, K. Gohel, U. Hegde, S. Gang, M. Rajapurkar, S. Erdogmus, S. Sengul, S. Kocak, I. Kurultak, S. Kutlay, K. Keven, B. Erbay, S. Erturk, S. Kimura, J. Imura, H. Atsumi, K. Fujimoto, Y. Chikazawa, M. Nakagawa, T. Hayama, H. Okuyama, H. Yamaya, H. Yokoyama, C. Libetta, M. Canevari, V. Sepe, E. Margiotta, F. Meloni, C. Martinelli, I. Borettaz, P. Esposito, V. Portalupi, M. Morosini, N. Solari, A. Dal Canton, K. Rusai, C. Schmaderer, R. Hermans, J. Lutz, U. Heemann, M. Baumann, V. Cantaluppi, M. Tamagnone, S. Dellepiane, D. Medica, C. Dolla, M. Messina, A. M. Manzione, G. Tognarelli, A. Ranghino, L. Biancone, G. Camussi, G. P. Segoloni, S. Ozkurt, G. Sahin, N. Degirmenci, G. Temiz, A. Musmul, A. Birdane, M. Tek, N. Tekin, F. Akyuz, A. U. Yalcin, A. Lopez-Valverde
Publikováno v:
Clinical Kidney Journal. 4:4.s2.42-4.s2.42